President Trump once again honed in on the high cost of USA prescription drugs on Thursday morning, praising Novartis and Pfizer for their recent decisions not to raise prices.
"We applaud Pfizer for this decision and hope other companies do the same", Trump said in a July 10 tweet.
Benzema s'énerve deux fois en une journée — Real
Meilleur buteur de l'histoire du club, l'attaquant uruguayen a inscrit son nom au panthéon du club de la capitale. Il y a un accord entre (le nouvel entraîneur Carlo) Ancelotti et moi pour acheter uniquement de jeunes joueurs.
Facing pressure from the Trump administration and lawmakers, Swiss drugmaker Novartis has also halted anticipated price increases. In 2017, Merck issued its second annual Pricing Action Transparency Report, which showed that net prices across Merck's USA product portfolio declined by 1.9 percent.
President TrumpDonald John TrumpNFL freezes policy barring players from protesting during anthem McConnell spokesman on Putin visit: "There is no invitation from Congress" Petition urges University of Virginia not to hire Marc Short MORE and Health and Human Services Secretary Alex Azar met with Pfizer CEO Ian Read Thursday amid the administration's campaign to get drug companies to lower prices, according to a White House spokesman. In addition, Merck said it would not increase the average net price of other medications by more than the inflation rate. "We thought that was prudent, given the dynamic environment we're now in", he said.
Merck plans to lower the prices of seven drugs, including Zepatier, a drug for heaptitis-c, by 60 percent.
Man City's World Cup players set to miss start of EPL season
The Premier League champions started their pre-season with a loss to German side on Friday. "I think it's the past now". Manchester City boss Pep Guardiola has admitted he missed out on an "exceptional player" in Jorginho.
In May, President Donald Trump issued a blueprint for bolstering competition and reducing regulations in the drug industry. But the companies have garnered praise from Trump, who has assumed bragging rights for being successful in lowering drug prices.
Pharmaceutical Research and Manufacturers of America spent $5.54 million between April and June, down 7.7 percent from the same period a year ago, according to disclosures released by the federal government on Friday.
" L'Etat-nation juif " soulève un tollé en Israël !
Le Premier ministre Benyamin Netanyahou, qui avait fait de ce texte son cheval de bataille, s'est lui félicité du vote. Enfin, la Turquie a estimé qu'elle " foulait aux pieds " le droit international et les droits des Arabes israéliens.